Lawrence Elmer is a Neurology physician affiliated with University of Toledo. OpenAlex indexes 63 publications with 3,408 citations (h-index 26); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2130 W. Central Avenue
Toledo, OH 436063819
Telephone
419-291-3900Registry record last updated 3 Jun 2025.
Clinical trials
- Impact of Switching to Continuous Release Dopamine Agonists
Sponsor: University of Toledo
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ACADIA Pharmaceuticals IncProgram year202539 payments$48,354openpaymentsdata.cms.gov ↗
- Teva Pharmaceuticals USA, Inc.Program year202518 payments$44,995openpaymentsdata.cms.gov ↗
- Neurocrine BioSciences, Inc.Program year202529 payments$40,167openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
97%Aromatic Amino Acid Decarboxylation Inhibitor32.2%Carbidopa-Levodopa Er46%Carbidopa-Levodopa43%Rytary11%Part D≥104 patientsAtypical Antipsychotic11.5%Nuplazid52%Risperidone20%Quetiapine Fumarate12%Clozapine9%Olanzapine6%Part D<11 patients+ 18 more classes in this area
Cardiovascular
1.7%Beta blocker0.7%Propranolol Hcl Er100%Part D<11 patientsCentral alpha-2 Adrenergic Agonist0.5%Clonidine Hcl100%Part D<11 patients+ 1 more class in this area
Musculoskeletal
0.7%gamma-Aminobutyric Acid-ergic Agonist0.7%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Lance Dworkin, MD
University of Toledo
Gretchen Tietjen, MD
University of Toledo
Daniel Rapport, MD
University of Toledo
Nourhan Chaaban
University of Toledo
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”